Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination

What Was Tested

The paper reports a study of hCG (human chorionic gonadotropin) and Triptorelin, published as a randomized controlled trial.

To compare the hormonal profile when using triptorelin vs. human chorionic gonadotropin (hCG) to trigger ovulation in intrauterine insemination (IUI) cycles.

Who Took Part

By PubMed's age tags, the people studied were adults, women only.

Twenty-five patients who underwent 48 cycles were enrolled in a prospective, randomized, crossover study.

How the Study Was Run

The researchers set it up as a randomized and crossover study.

The participants were allocated by chance, so the hCG (human chorionic gonadotropin) group and the comparison group should start out alike.

In the crossover set-up each of the participants took both hCG (human chorionic gonadotropin) and the comparison in turn, acting as their own control.

Blood was collected the day of hCG/triptorelin administration and both days after IUI.

What Was Measured

Topics PubMed links to this paper include Chorionic Gonadotropin, Follicle Stimulating Hormone, Gonadotropin-Releasing Hormone, Insemination, Artificial, Luteinizing Hormone, Oocytes and Ovulation Induction.

What This Means in Plain Language

The paper is a randomized and crossover study of hCG (human chorionic gonadotropin) and Triptorelin.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2008 (The Journal of reproductive medicine), a journal based in United States.

More context: the hCG (human chorionic gonadotropin) compound page and the Triptorelin compound page, all human trials.